Time to recurrence is a significant predictor of cancer‐specific survival after recurrence in patients with recurrent renal cell carcinoma – results from a comprehensive multi‐centre database (<scp>CORONA</scp>/<scp>SATURN</scp>‐<scp>P</scp>roject)
Distribution of the number of citations over years.